Product How it works Pricing Blog FAQ About Contact
BIO-RAD Laboratories

BIO-RAD Laboratories (NYSE: BIO) revenue

BIO-RAD Laboratories reported revenue of $2,583m for fiscal 2025, 0.7% more than in fiscal 2024 ($2,567m). Since fiscal 2016 its revenue has grown by 24.9%, an average growth of 2.5% a year.

BIO-RAD Laboratories's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2023, −4.7%.

Revenue, in millions of US dollars2,06820162,16020172,28920182,31220192,54620202,92320212,80220222,67120232,56720242,5832025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$2,583m+0.7%$47.2m1.8%
2024$2,567m−3.9%$269.0m10.5%
2023$2,671m−4.7%$337.8m12.6%
2022$2,802m−4.1%$482.6m17.2%
2021$2,923m+14.8%$500.3m17.1%
2020$2,546m+10.1%$421.3m16.6%
2019$2,312m+1.0%$229.7m9.9%
2018$2,289m+6.0%−$103.3m−4.5%
2017$2,160m+4.4%$119.3m5.5%
2016$2,068m—$55.7m2.7%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

BIO-RAD Laboratories revenue compared with its sector

By revenue for its latest fiscal year, BIO-RAD Laboratories ranks 99th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; BIO-RAD Laboratories, 0.7%.

RankCompanyRevenueRevenue growth
97thEnvista$2,720m8.3%
98thInsulet$2,708m30.7%
99thBIO-RAD Laboratories$2,583m0.7%
100thMedpace$2,530m20.0%
101stChemed$2,530m4.1%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of BIO-RAD Laboratories

How much revenue did BIO-RAD Laboratories make in fiscal 2025?
BIO-RAD Laboratories reported revenue of $2,583m for fiscal 2025, compared with $2,567m in fiscal 2024.
How much has the revenue of BIO-RAD Laboratories grown?
Between fiscal 2016 and fiscal 2025 it went from $2,068m to $2,583m: 24.9% more, an average growth of 2.5% a year.
What was the best year for revenue at BIO-RAD Laboratories?
Of its last 10 fiscal years, fiscal 2021, with $2,923m.
Where does BIO-RAD Laboratories rank in its sector by revenue?
It ranks 99th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for BIO-RAD Laboratories come from?
From the annual report (Form 10-K) that BIO-RAD Laboratories files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that BIO-RAD Laboratories files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on BIO-RAD Laboratories: the BIO-RAD Laboratories page · annual accounts · net income.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.